查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2148907

動物用藥品市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測。

Animal Health Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

動物保健市場的成長要素

全球動物保健市場預計在2025年達到701.6億美元，從2026年的782.7億美元成長至2034年的1,877.9億美元，2026年至2034年的複合年成長率（CAGR）為11.56%。 2025年，北美以34.02%的市佔率引領全球市場。該市場涵蓋用於預防、診斷和治療牲畜及伴侶動物疾病的藥品、疫苗、診斷試劑、藥用飼料和營養產品。

醫療保健在食品安全、通用感染疾病預防、畜牧業生產力以及伴侶動物健康等領域的重要性日益凸顯，這正在推動市場成長。預計北美將繼續保持領先地位，到2025年銷售額將達到141.2億美元。

市場趨勢

動物保健市場的發展趨勢日益聚焦於預防性醫療保健、先進診斷、數位監測和伴侶動物健康。寵物數量的成長以及人們態度從單純的「擁有寵物」向「成為寵物主人」的轉變，正在推動預防保健、慢性病管理、診斷和高階治療方面的支出。

此外，數位化正透過遠端監測、臨床管理軟體、數據分析和連線健診設備改變獸醫學。官民合作關係正在提高獸醫服務的可及性並支持疾病預防計畫。永續性措施正促使製造商開發生技藥品、免疫調節劑、功能性飼料添加劑和傳統抗菌劑的替代品。

市場促進因素

通用感染疾病發生率上升：

人們對動物性疾病的認知不斷提高，促使各國政府、農民、獸醫和寵物飼主採取預防性醫療保健措施。疾病監測系統的加強和食品安全標準的日益嚴格，也推動了對疫苗、診斷試劑和治療藥物的需求。

對動物源性蛋白質的需求不斷增加：

全球蛋白質消費量的成長促使畜牧養殖戶提高動物生產力並減少疾病損失。疫苗接種、寄生蟲控制、畜群診斷和營養解決方案正成為現代畜牧管理的重要組成部分。

研發活動活性化：

獸醫學領域的持續研究為先進藥物、疫苗、診斷試劑和營養產品的開發提供了支持。生技藥品、分子診斷和精準醫療領域的創新正在創造更多市場機會。

市場限制與挑戰

嚴格的監理要求：

動物用藥品和疫苗的核准流程耗時耗力，仍是限制市場發展的因素。開發新的動物產品可能需要大量投資、數年的研發以及監管檢驗。

其他挑戰包括抗菌藥物使用限制、產品開發成本高、獸醫基礎設施不平衡、新興市場合格專業人員短缺、畜牧養殖戶對成本敏感以及某些地區預防保健意識低下。

細分分析

按產品分類的市場細分包括藥品、疫苗、飼料和診斷試劑。到2025年，藥品將佔據45.5%的市場佔有率，成為最大的細分市場，這主要得益於對感染疾病、寄生蟲感染和慢性病治療藥物的需求。隨著預防性和精準醫療的普及，疫苗和診斷試劑的重要性日益凸顯。

依動物種類分類：市場包括牲畜和伴侶動物。到2025年，伴侶動物將佔據最大佔有率，這主要得益於寵物數量的增加、寵物「人性化」趨勢以及對先進獸醫護理投入的增加。由於疾病管制和食品生產的需求，牲畜仍將佔據重要地位。

按最終用戶分類：主要最終用戶包括獸醫醫院和診所、動物護理和復健中心以及診斷中心。雖然獸醫醫院和診所仍保持領先地位，但隨著分子檢測和醫療保健服務的普及，診斷中心也不斷擴張。

區域分析

憑藉先進的獸醫基礎設施、強大的研發能力、高額的伴侶動物支出和大規模的畜牧養殖業務，預計到 2025 年，北美將以 34.02% 的市場佔有率引領全球市場。

歐洲排名第二，這得益於嚴格的動物健康法規、廣泛的預防性醫療保健和食品安全要求。

亞太地區預計將迎來強勁成長，這主要得益於畜牧業存量增加、蛋白質消費量上升、寵物飼養量成長以及獸醫基礎設施改善。日本受益於對先進獸醫護理和慢性病管理日益成長的需求，而中國則受益於畜牧業現代化和都市區伴侶動物醫療需求的成長。

在拉丁美洲、中東和非洲，隨著獸醫基礎設施、疾病控制計劃和技術應用的進步，預計將出現商業機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇

第4章：主要考慮因素

  • 近期產業趨勢，例如併購
  • 主要國家主要獸醫疾病的流行情況
  • 主要國家寵物擁有情況統計數據
  • 主要國家寵物保險概覽
  • 獸藥產品的技術進步
  • 主要行業趨勢

第5章：2021-2034年全球動物用藥品市場分析、洞察與預測

  • 主要發現與總結
  • 市場分析、洞察與預測：按產品分類。
    • 製藥
      • 抗感染藥物
      • 消炎（藥）
      • 殺蟲劑
      • 其他
    • 疫苗
    • 飼料
    • 診斷
      • 裝置
      • 試劑和耗材
  • 市場分析、洞察與預測：依動物種類分類
    • 家畜
    • 伴侶動物
  • 市場分析、洞察與預測：按最終用戶分類
    • 獸醫醫院和診所
    • 動物照護與復健中心
    • 診斷中心
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美動物用藥品市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲動物用藥品市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區動物用藥品市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲動物用藥品市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲動物用藥品市場分析、洞察與預測（2021-2034年）

  • 國家
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 主要行業趨勢
  • 全球市佔率分析（2025 年）
  • 競爭對手儀錶板
  • 主要公司比較分析
  • 公司簡介
    • Zoetis
    • Intervet Inc.
    • Elanco
    • Ceva
    • Virbac
    • Merck & Co., Inc.
    • Novartis AG
    • Emergent BioSolutions, Inc.
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Other Prominent Players

第12章 戰略建議

Product Code: FBI102371

Growth Factors of animal health Market

The global animal health market size was valued at USD 70.16 billion in 2025 and is projected to grow from USD 78.27 billion in 2026 to USD 187.79 billion by 2034, registering a CAGR of 11.56% during 2026-2034. North America dominated the global market with a 34.02% market share in 2025. The market includes pharmaceuticals, vaccines, diagnostics, medicated animal feeds, and nutritional products used to prevent, diagnose, and treat diseases in livestock and companion animals.

The increasing importance of veterinary healthcare in food security, zoonotic disease prevention, livestock productivity, and companion animal wellness is supporting market growth. North America generated USD 14.12 billion in revenue in 2025, maintaining its leading position.

Market Trends

The animal health market trends are increasingly centered on preventive healthcare, advanced diagnostics, digital monitoring, and companion animal wellness. Growing pet adoption and the shift from pet ownership toward pet parenthood are encouraging spending on preventive care, chronic disease management, diagnostics, and premium therapeutics.

Digitalization is also transforming veterinary healthcare through remote monitoring, practice-management software, data analytics, and connected health devices. Public-private partnerships are improving veterinary service availability and supporting disease prevention programs. Sustainability is encouraging manufacturers to develop biologics, immunomodulators, functional feed additives, and alternatives to traditional antimicrobials.

Market Drivers

Rising Incidence of Zoonotic Diseases:

Increasing awareness of animal-borne diseases is encouraging governments, farmers, veterinarians, and pet owners to adopt preventive healthcare solutions. Stronger disease surveillance and food-safety requirements are supporting demand for vaccines, diagnostics, and therapeutics.

Growing Demand for Animal-Derived Protein:

Rising global protein consumption is encouraging livestock producers to improve animal productivity and reduce disease-related losses. Preventive vaccination, parasite control, herd diagnostics, and nutritional solutions are becoming important components of modern livestock management.

Increasing R&D Activities:

Continuous research in veterinary medicine is supporting the development of advanced drugs, vaccines, diagnostics, and nutritional products. Innovations in biologics, molecular diagnostics, and precision healthcare are creating additional market opportunities.

Market Restraints and Challenges

Stringent Regulatory Requirements:

The lengthy and expensive approval process for animal drugs and vaccines remains a major market restraint. Development of new veterinary products can require substantial investment and several years of research and regulatory validation.

Additional challenges include antimicrobial-use restrictions, high product-development costs, uneven veterinary infrastructure, limited access to trained professionals in emerging markets, livestock producer cost sensitivity, and limited awareness of preventive healthcare in certain regions.

Segmentation Analysis

By Product: The market is segmented into drugs, vaccines, feed, and diagnostics. Drugs represented the largest segment with a 45.5% share in 2025, supported by demand for treatments against infectious diseases, parasites, and chronic conditions. Vaccines and diagnostics are gaining importance as preventive and precision healthcare adoption increases.

By Animal: The market includes livestock animals and companion animals. Companion animals held the largest share in 2025, supported by increasing pet adoption, pet humanization, and growing spending on advanced veterinary care. Livestock remains important because of disease-control and food-production requirements.

By End User: Key end users include veterinary hospitals and clinics, animal care and rehabilitation centers, diagnostic centers, and others. Veterinary hospitals and clinics maintain a leading position, while diagnostic centers are expanding with increased adoption of molecular testing and preventive healthcare.

Regional Analysis

North America led the global market with a 34.02% share in 2025, supported by advanced veterinary infrastructure, strong R&D, high companion animal spending, and large-scale livestock operations.

Europe held the second-largest position, supported by stringent animal health regulations, preventive healthcare adoption, and food-safety requirements.

Asia Pacific is expected to witness healthy growth due to expanding livestock populations, rising protein consumption, increasing pet ownership, and improving veterinary infrastructure. Japan benefits from advanced veterinary care and increasing demand for chronic disease management, while China is experiencing increasing demand linked to livestock modernization and urban companion animal healthcare.

Latin America and the Middle East & Africa are also expected to provide opportunities as veterinary infrastructure, disease-control programs, and technology adoption improve.

Key Industry Players

Major companies operating in the animal health market include Zoetis, Intervet International B.V., Elanco, Ceva, Virbac, Merck & Co., Inc., Novartis AG, Emergent BioSolutions, CSL Limited, IDEXX Laboratories, Bayer AG, and Boehringer Ingelheim International GmbH.

Recent Industry Developments

Recent industry developments include expansion of companion animal biologics, strategic acquisitions in veterinary diagnostics, advanced livestock vaccines, digital herd-health monitoring solutions, and innovative parasiticide formulations. These developments demonstrate the industry's increasing focus on preventive care, diagnostics, digitalization, and specialized therapies.

Future Outlook

The animal health market outlook remains positive through 2034. The market is projected to increase from USD 70.16 billion in 2025 to USD 78.27 billion in 2026 and USD 187.79 billion by 2034. IoT-enabled monitoring, connected veterinary devices, precision diagnostics, advanced biologics, preventive vaccination, and public-private partnerships are expected to reshape the industry.

Conclusion

The global animal health market is experiencing strong expansion as livestock producers and companion animal owners increasingly prioritize disease prevention, early diagnosis, and advanced treatment. Rising zoonotic disease concerns, protein consumption, pet humanization, technological innovation, and veterinary R&D are creating sustained market opportunities. Although regulatory requirements, development costs, antimicrobial restrictions, and infrastructure gaps remain challenges, continued innovation and improved healthcare accessibility are expected to support substantial market growth through 2034.

Unit Value (USD Billion)

Segmentation By Product

  • Drugs
    • Anti-Infectives
    • Anti-Inflammatory
    • Parasiticides
    • Others
  • Vaccines
  • Feed
  • Diagnostics
    • Instruments
    • Reagents & Consumables

By Animal

  • Livestock Animals
  • Companion Animals

By End-user

  • Veterinary Hospitals & Clinics
  • Animal Care & Rehabilitation Centers
  • Diagnostic Centers
  • Others

By Geography

  • North America (the U.S. and Canada)
  • Europe (UK, Germany, France, Scandinavia, and the Rest of Europe)
  • Asia Pacific (Japan, China, India, Southeast Asia, and the Rest of Asia Pacific)
  • Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Recent Industry Developments Such as Mergers & Acquisitions
  • 4.2. Prevalence of Key Veterinary Diseases, in Major Countries
  • 4.3. Pet Ownership Statistics, in Key Countries
  • 4.4. Overview of Pet Insurance, in Key Countries
  • 4.5. Technological Advancements in Veterinary Care products
  • 4.6. Key Industry Trends

5. Global Animal Health Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Analysis, Insights and Forecast - By Product
    • 5.2.1. Drugs
      • 5.2.1.1. Anti-Infectives
      • 5.2.1.2. Anti-Inflammatory
      • 5.2.1.3. Parasiticides
      • 5.2.1.4. Others
    • 5.2.2. Vaccines
    • 5.2.3. Feed
    • 5.2.4. Diagnostics
      • 5.2.4.1. Instruments
      • 5.2.4.2. Reagents & Consumables
  • 5.3. Market Analysis, Insights and Forecast - By Animal
    • 5.3.1. Livestock Animals
    • 5.3.2. Companion Animals
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Veterinary Hospitals & Clinics
    • 5.4.2. Animal Care & Rehabilitation Centers
    • 5.4.3. Diagnostic Centers
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Animal Health Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Analysis - By Product
    • 6.2.1. Drugs
      • 6.2.1.1. Anti-Infectives
      • 6.2.1.2. Anti-Inflammatory
      • 6.2.1.3. Parasiticides
      • 6.2.1.4. Others
    • 6.2.2. Vaccines
    • 6.2.3. Feed
    • 6.2.4. Diagnostics
      • 6.2.4.1. Instruments
      • 6.2.4.2. Reagents & Consumables
  • 6.3. Market Analysis - By Animal
    • 6.3.1. Livestock Animals
    • 6.3.2. Companion Animals
  • 6.4. Market Analysis - By End User
    • 6.4.1. Veterinary Hospitals & Clinics
    • 6.4.2. Animal Care & Rehabilitation Centers
    • 6.4.3. Diagnostic Centers
    • 6.4.4. Others
  • 6.5. Market Analysis - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Animal Health Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Analysis - By Product
    • 7.2.1. Drugs
      • 7.2.1.1. Anti-Infectives
      • 7.2.1.2. Anti-Inflammatory
      • 7.2.1.3. Parasiticides
      • 7.2.1.4. Others
    • 7.2.2. Vaccines
    • 7.2.3. Feed
    • 7.2.4. Diagnostics
      • 7.2.4.1. Instruments
      • 7.2.4.2. Reagents & Consumables
  • 7.3. Market Analysis - By Animal
    • 7.3.1. Livestock Animals
    • 7.3.2. Companion Animals
  • 7.4. Market Analysis - By End User
    • 7.4.1. Veterinary Hospitals & Clinics
    • 7.4.2. Animal Care & Rehabilitation Centers
    • 7.4.3. Diagnostic Centers
    • 7.4.4. Others
  • 7.5. Market Analysis - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Animal Health Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. Market Analysis - By Product
    • 8.2.1. Drugs
      • 8.2.1.1. Anti-Infectives
      • 8.2.1.2. Anti-Inflammatory
      • 8.2.1.3. Parasiticides
      • 8.2.1.4. Others
    • 8.2.2. Vaccines
    • 8.2.3. Feed
    • 8.2.4. Diagnostics
      • 8.2.4.1. Instruments
      • 8.2.4.2. Reagents & Consumables
  • 8.3. Market Analysis - By Animal
    • 8.3.1. Livestock Animals
    • 8.3.2. Companion Animals
  • 8.4. Market Analysis - By End User
    • 8.4.1. Veterinary Hospitals & Clinics
    • 8.4.2. Animal Care & Rehabilitation Centers
    • 8.4.3. Diagnostic Centers
    • 8.4.4. Others
  • 8.5. Market Analysis - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Animal Health Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. Market Analysis - By Product
    • 9.2.1. Drugs
      • 9.2.1.1. Anti-Infectives
      • 9.2.1.2. Anti-Inflammatory
      • 9.2.1.3. Parasiticides
      • 9.2.1.4. Others
    • 9.2.2. Vaccines
    • 9.2.3. Feed
    • 9.2.4. Diagnostics
      • 9.2.4.1. Instruments
      • 9.2.4.2. Reagents & Consumables
  • 9.3. Market Analysis - By Animal
    • 9.3.1. Livestock Animals
    • 9.3.2. Companion Animals
  • 9.4. Market Analysis - By End User
    • 9.4.1. Veterinary Hospitals & Clinics
    • 9.4.2. Animal Care & Rehabilitation Centers
    • 9.4.3. Diagnostic Centers
    • 9.4.4. Others
  • 9.5. Market Analysis - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Animal Health Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Key Findings / Summary
  • 10.2. Market Analysis - By Product
    • 10.2.1. Drugs
      • 10.2.1.1. Anti-Infectives
      • 10.2.1.2. Anti-Inflammatory
      • 10.2.1.3. Parasiticides
      • 10.2.1.4. Others
    • 10.2.2. Vaccines
    • 10.2.3. Feed
    • 10.2.4. Diagnostics
      • 10.2.4.1. Instruments
      • 10.2.4.2. Reagents & Consumables
  • 10.3. Market Analysis - By Animal
    • 10.3.1. Livestock Animals
    • 10.3.2. Companion Animals
  • 10.4. Market Analysis - By End User
    • 10.4.1. Veterinary Hospitals & Clinics
    • 10.4.2. Animal Care & Rehabilitation Centers
    • 10.4.3. Diagnostic Centers
    • 10.4.4. Others
  • 10.5. Market Analysis - By Country/Sub-region
    • 10.5.1. GCC Countries
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Key Industry Developments
  • 11.2. Global Market Share Analysis (2025)
  • 11.3. Competition Dashboard
  • 11.4. Comparative Analysis - Major Players
  • 11.5. Company Profiles
    • 11.5.1. Zoetis
      • 11.5.1.1. Overview,
      • 11.5.1.2. Products & services,
      • 11.5.1.3. SWOT analysis,
      • 11.5.1.4. Recent developments,
      • 11.5.1.5. strategies,
      • 11.5.1.6. financials (based on availability)
    • 11.5.2. Intervet Inc.
      • 11.5.2.1. Overview,
      • 11.5.2.2. Products & services,
      • 11.5.2.3. SWOT analysis,
      • 11.5.2.4. Recent developments,
      • 11.5.2.5. strategies,
      • 11.5.2.6. financials (based on availability)
    • 11.5.3. Elanco
      • 11.5.3.1. Overview,
      • 11.5.3.2. Products & services,
      • 11.5.3.3. SWOT analysis,
      • 11.5.3.4. Recent developments,
      • 11.5.3.5. strategies,
      • 11.5.3.6. financials (based on availability)
    • 11.5.4. Ceva
      • 11.5.4.1. Overview,
      • 11.5.4.2. Products & services,
      • 11.5.4.3. SWOT analysis,
      • 11.5.4.4. Recent developments,
      • 11.5.4.5. strategies,
      • 11.5.4.6. financials (based on availability)
    • 11.5.5. Virbac
      • 11.5.5.1. Overview,
      • 11.5.5.2. Products & services,
      • 11.5.5.3. SWOT analysis,
      • 11.5.5.4. Recent developments,
      • 11.5.5.5. strategies,
      • 11.5.5.6. financials (based on availability)
    • 11.5.6. Merck & Co., Inc.
      • 11.5.6.1. Overview,
      • 11.5.6.2. Products & services,
      • 11.5.6.3. SWOT analysis,
      • 11.5.6.4. Recent developments,
      • 11.5.6.5. strategies,
      • 11.5.6.6. financials (based on availability)
    • 11.5.7. Novartis AG
      • 11.5.7.1. Overview,
      • 11.5.7.2. Products & services,
      • 11.5.7.3. SWOT analysis,
      • 11.5.7.4. Recent developments,
      • 11.5.7.5. strategies,
      • 11.5.7.6. financials (based on availability)
    • 11.5.8. Emergent BioSolutions, Inc.
      • 11.5.8.1. Overview,
      • 11.5.8.2. Products & services,
      • 11.5.8.3. SWOT analysis,
      • 11.5.8.4. Recent developments,
      • 11.5.8.5. strategies,
      • 11.5.8.6. financials (based on availability)
    • 11.5.9. Bayer AG
      • 11.5.9.1. Overview,
      • 11.5.9.2. Products & services,
      • 11.5.9.3. SWOT analysis,
      • 11.5.9.4. Recent developments,
      • 11.5.9.5. strategies,
      • 11.5.9.6. financials (based on availability)
    • 11.5.10. Boehringer Ingelheim International GmbH
      • 11.5.10.1. Overview,
      • 11.5.10.2. Products & services,
      • 11.5.10.3. SWOT analysis,
      • 11.5.10.4. Recent developments,
      • 11.5.10.5. strategies,
      • 11.5.10.6. financials (based on availability)
    • 11.5.11. Other Prominent Players
      • 11.5.11.1. Overview,
      • 11.5.11.2. Products & services,
      • 11.5.11.3. SWOT analysis,
      • 11.5.11.4. Recent developments,
      • 11.5.11.5. strategies,
      • 11.5.11.6. financials (based on availability)

12. Strategic Recommendations

List of Tables

  • Table 1: Global Animal Health Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 2: Global Animal Health Market Revenue (US$ Mn) Forecast, by Drugs, 2021-2034
  • Table 3: Global Animal Health Market Revenue (US$ Mn) Forecast, by Diagnostics, 2021-2034
  • Table 4: Global Animal Health Market Revenue (US$ Mn) Forecast, by Animal, 2021-2034
  • Table 5: Global Animal Health Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
  • Table 6: Global Animal Health Market Revenue (US$ Mn) Forecast, by Region, 2021-2034
  • Table 7: North America Animal Health Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 8: North America Animal Health Market Revenue (US$ Mn) Forecast, by Drugs, 2021-2034
  • Table 9: North America Animal Health Market Revenue (US$ Mn) Forecast, by Diagnostics, 2021-2034
  • Table 10: North America Animal Health Market Revenue (US$ Mn) Forecast, by Animal, 2021-2034
  • Table 11: North America Animal Health Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
  • Table 12: North America Animal Health Market Revenue (US$ Mn) Forecast, By Country, 2021-2034
  • Table 13: Europe Animal Health Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 14: Europe Animal Health Market Revenue (US$ Mn) Forecast, by Drugs, 2021-2034
  • Table 15: Europe Animal Health Market Revenue (US$ Mn) Forecast, by Diagnostics, 2021-2034
  • Table 16: Europe Animal Health Market Revenue (US$ Mn) Forecast, by Animal, 2021-2034
  • Table 17: Europe Animal Health Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
  • Table 18: Europe Animal Health Market Revenue (US$ Mn) Forecast, By Country/Sub-region, 2021-2034
  • Table 19: Asia Pacific Animal Health Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 20: Asia Pacific Animal Health Market Revenue (US$ Mn) Forecast, by Drugs, 2021-2034
  • Table 21: Asia Pacific Animal Health Market Revenue (US$ Mn) Forecast, by Diagnostics, 2021-2034
  • Table 22: Asia Pacific Animal Health Market Revenue (US$ Mn) Forecast, by Animal, 2021-2034
  • Table 23: Asia Pacific Animal Health Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
  • Table 24: Asia Pacific Animal Health Market Revenue (US$ Mn) Forecast, By Country/Sub-region, 2021-2034
  • Table 25: Latin America Animal Health Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 26: Latin America Animal Health Market Revenue (US$ Mn) Forecast, by Drugs, 2021-2034
  • Table 27: Latin America Animal Health Market Revenue (US$ Mn) Forecast, by Diagnostics, 2021-2034
  • Table 28: Latin America Animal Health Market Revenue (US$ Mn) Forecast, by Animal, 2021-2034
  • Table 29: Latin America Animal Health Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
  • Table 30: Latin America Animal Health Market Revenue (US$ Mn) Forecast, By Country/Sub-region, 2021-2034
  • Table 31: Middle East & Africa Animal Health Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 32: Middle East & Africa Animal Health Market Revenue (US$ Mn) Forecast, by Drugs, 2021-2034
  • Table 33: Middle East & Africa Animal Health Market Revenue (US$ Mn) Forecast, by Diagnostics, 2021-2034
  • Table 34: Middle East & Africa Animal Health Market Revenue (US$ Mn) Forecast, by Animal, 2021-2034
  • Table 34: Middle East & Africa Animal Health Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
  • Table 35: Middle East & Africa Animal Health Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Animal Health Market Revenue Breakdown (US$ Mn, %) by Region, 2025 & 2034
  • Figure 2: Global Animal Health Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Animal Health Market Forecast (US$ Mn), by Drugs, 2021-2034
  • Figure 4: Global Animal Health Market Forecast (US$ Mn), by Vaccines, 2021-2034
  • Figure 5: Global Animal Health Market Forecast (US$ Mn), by Feed, 2021-2034
  • Figure 6: Global Animal Health Market Forecast (US$ Mn), by Diagnostics, 2021-2034
  • Figure 7: Global Animal Health Market Value Share (%), by Animal, 2025 & 2034
  • Figure 8: Global Animal Health Market Forecast (US$ Mn), by Livestock Animal, 2021-2034
  • Figure 9: Global Animal Health Market Forecast (US$ Mn), by Companion Animal, 2021-2034
  • Figure 10: Global Animal Health Market Value Share (%), by End-user, 2025 & 2034
  • Figure 11: Global Animal Health Market Forecast (US$ Mn), by Veterinary Hospitals & Clinics, 2021-2034
  • Figure 12: Global Animal Health Market Forecast (US$ Mn), by Animal Care & Rehabilitation Centers, 2021-2034
  • Figure 13: Global Animal Health Market Forecast (US$ Mn), by Diagnostic Centers, 2021-2034
  • Figure 14: Global Animal Health Market Forecast (US$ Mn), by Others, 2021-2034
  • Figure 15: Global Animal Health Market Value (US$ Mn), by Region, 2025 & 2034
  • Figure 16: North America Animal Health Market Value (US$ Mn), by Product, 2025 & 2034
  • Figure 17: North America Animal Health Market Value Share (%), by Product, 2025
  • Figure 18: North America Animal Health Market Value (US$ Mn), by Animal, 2025 & 2034
  • Figure 19: North America Animal Health Market Value Share (%), by Animal, 2025
  • Figure 20: North America Animal Health Market Value (US$ Mn), by End-user, 2025 & 2034
  • Figure 21: North America Animal Health Market Value Share (%), by End-user, 2025
  • Figure 22: North America Animal Health Market Value (US$ Mn), By Country, 2025 & 2034
  • Figure 23: North America Animal Health Market Value Share (%), By Country, 2025
  • Figure 24: Europe Animal Health Market Value (US$ Mn), by Product, 2025 & 2034
  • Figure 25: Europe Animal Health Market Value Share (%), by Product, 2025
  • Figure 26: Europe Animal Health Market Value (US$ Mn), by Animal, 2025 & 2034
  • Figure 27: Europe Animal Health Market Value Share (%), by Animal, 2025
  • Figure 28: Europe Animal Health Market Value (US$ Mn), by End-user, 2025 & 2034
  • Figure 29: Europe Animal Health Market Value Share (%), by End-user, 2025
  • Figure 30: Europe Animal Health Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe Animal Health Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Asia Pacific Animal Health Market Value (US$ Mn), by Product, 2025 & 2034
  • Figure 33: Asia Pacific Animal Health Market Value Share (%), by Product, 2025
  • Figure 34: Asia Pacific Animal Health Market Value (US$ Mn), by Animal, 2025 & 2034
  • Figure 35: Asia Pacific Animal Health Market Value Share (%), by Animal, 2025
  • Figure 36: Asia Pacific Animal Health Market Value (US$ Mn), by End-user, 2025 & 2034
  • Figure 37: Asia Pacific Animal Health Market Value Share (%), by End-user, 2025
  • Figure 38: Asia Pacific Animal Health Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
  • Figure 39: Asia Pacific Animal Health Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 40: Latin America Animal Health Market Value (US$ Mn), by Product, 2025 & 2034
  • Figure 41: Latin America Animal Health Market Value Share (%), by Product, 2025
  • Figure 42: Latin America Animal Health Market Value (US$ Mn), by Animal, 2025 & 2034
  • Figure 43: Latin America Animal Health Market Value Share (%), by Animal, 2025
  • Figure 44: Latin America Animal Health Market Value (US$ Mn), by End-user, 2025 & 2034
  • Figure 45: Latin America Animal Health Market Value Share (%), by End-user, 2025
  • Figure 46: Latin America Animal Health Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
  • Figure 47: Latin America Animal Health Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 48: Middle East & Africa Animal Health Market Value (US$ Mn), by Product, 2025 & 2034
  • Figure 49: Middle East & Africa Animal Health Market Value Share (%), by Product, 2025
  • Figure 50: Middle East & Africa Animal Health Market Value (US$ Mn), by Animal, 2025 & 2034
  • Figure 51: Middle East & Africa Animal Health Market Value Share (%), by Animal, 2025
  • Figure 52: Middle East & Africa Animal Health Market Value (US$ Mn), by End-user, 2025 & 2034
  • Figure 53: Middle East & Africa Animal Health Market Value Share (%), by End-user, 2025
  • Figure 54: Middle East & Africa Animal Health Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
  • Figure 55: Middle East & Africa Animal Health Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 56: Global Animal Health Market Share (%), By Company, 2025